Apricot must decide how to commercialize iPhat, a patented BMI-measuring wearable technology. The case guides candidates through market sizing the $3B smartwatch industry, analyzing entry barriers (Apple dominates with 50% share), calculating break-even requirements (3M units needed = 20% market share), identifying alternative applications, and weighing build-vs-license strategies.
Key Insights:
- Market entry into smartwatches requires becoming the #2 player behind Apple ($600M revenue) to break even with $240M capital investment, indicating extremely high barriers to entry
- Licensing iPhat to existing smartwatch manufacturers is a superior strategy given market concentration and avoiding cannibalization of existing Apricot products
- Alternative applications (healthcare targeting obesity/heart disease, smart sneakers integration) offer lower-risk, higher-margin opportunities than direct smartwatch market competition
- Break-even analysis reveals the importance of distinguishing fixed vs. variable costs (contribution margin = ($200-$48-$40-$32)/$200 = 40%) when evaluating feasibility